Investor Alert

Alphabet Inc. Cl A



After Hours

 --Quotes are delayed by 20 min

Nov 26, 2021, 4:59 p.m.





-2.65 -0.09%


Volume 66,009

Quotes are delayed by 20 min


Previous close

$ 2,922.40

$ 2,843.66


-78.74 -2.69%

Day low

Day high




52 week low

52 week high




Robin L. Washington

Currently, Robin L. Washington occupies the position of Managing Director at Gilead Sciences GmbH and Chief Financial Officer at Kite Pharma, Inc. Ms. Washington is also Member-Presidents Council at the University of Michigan and Chief Development Officer at Catalyst Partners Acquisition Corp. and on the board of 12 other companies.

In her past career she held the position of CFO, Chief Accounting Officer & Executive VP at Gilead Sciences, Inc. and Chief Financial Officer at Pharmasset, Inc. (a subsidiary of Gilead Sciences, Inc.), Chief Financial Officer of Hyperion Solutions Corp., Finance Director at Tandem Computers, Inc., Senior Auditor at Deloitte & Touche LLP, Accounting Analyst at Federal Reserve Bank of Chicago and Senior Vice President & Controller at PeopleSoft, Inc.

Ms. Washington received an MBA from Pepperdine University and an undergraduate degree from the University of Michigan.


Date Shares Transaction Value
07/07/2021 140   Award at $0 per share. 0
07/01/2020 245   Award at $0 per share. 0
07/03/2019 47   Award at $0 per share. 0
05/01/2019 842   Award at $0 per share. 0

Officers and Executives

Mr. Sundar Pichai
Chief Executive Officer & Director
Ms. Ruth M. Porat
Chief Financial Officer & Senior Vice President
Dr. Robert M. Califf
Head-Strategy & Policy
Mr. Torrence N. Boone
Vice President-Global Client Partnerships
Ms. Jewel M. Burks
Head-Google for Startups
Mr. Yolande G. Piazza
Vice President-Financial Services
Ms. Asmau Ahmed
Managing Director
Mr. Cory R. Ondrejka
Vice President
Ms. Eileen Naughton
Vice President-People Operations
Dr. Frances Hamilton Arnold
Mr. Lawrence E. Page
Mr. Sergey Mikhaylovich Brin
Mr. Amie Thuerner O'Toole
Chief Accounting Officer & Vice President
Ms. Ellen West
Vice President-Investor Relations
Ms. Cynthia M. Patton
General Counsel & Secretary
Dr. John LeRoy Hennessy
Mr. Louis John Doerr
Independent Director
Ms. Ann Mather
Independent Director
Mr. Alan R. Mulally
Independent Director
Mr. Ram Kavitarak Shriram
Independent Director
Dr. Roger Walton Ferguson
Independent Director
Ms. Robin L. Washington
Independent Director
Link to MarketWatch's Slice.